Sekar Kathiresan

Insider Reports History

Entity
Individual
Location
500 Technology Square, Cambridge, MA
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Sekar Kathiresan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sekar Kathiresan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. Chief Executive Officer, Director Common Stock 347K $1.44M $4.15 Apr 2, 2025 Direct
Verve Therapeutics, Inc. Chief Executive Officer, Director Common Stock 241K $1M $4.15 Apr 1, 2025 Kathiresan Family 2021 Irrevocable Trust
Verve Therapeutics, Inc. Chief Executive Officer, Director Common Stock 111K $461K $4.15 Apr 1, 2025 Sekar Kathiresan 2021 Irrevocable Trust
Verve Therapeutics, Inc. Chief Executive Officer, Director Restricted Stock Units 99K $411K $4.15 Apr 1, 2025 Direct
Verve Therapeutics, Inc. Chief Executive Officer, Director Stock Option (right to buy) 150K Jan 8, 2025 Direct
Maze Therapeutics, Inc. Director Common Stock 104K Jan 30, 2025 Direct
Relay Therapeutics, Inc. Director Stock Option (Right to Buy) 102K Jun 3, 2024 Direct

Insider Reports Filed by Sekar Kathiresan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERV Verve Therapeutics, Inc. Apr 1, 2025 3 -$40.8K 4 Apr 3, 2025 Chief Executive Officer, Director
MAZE Maze Therapeutics, Inc. Jan 30, 2025 0 $0 3 Jan 30, 2025 Director
VERV Verve Therapeutics, Inc. Jan 8, 2025 3 $0 4 Jan 10, 2025 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Dec 4, 2024 2 $0 4 Dec 4, 2024 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Jun 28, 2024 2 $86.1K 4 Jul 2, 2024 Chief Executive Officer, Director
RLAY Relay Therapeutics, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Director
VERV Verve Therapeutics, Inc. Feb 14, 2024 2 $0 4 Feb 16, 2024 Chief Executive Officer, Director
RLAY Relay Therapeutics, Inc. May 31, 2023 1 $0 4 Jun 1, 2023 Director
VERV Verve Therapeutics, Inc. Feb 14, 2023 1 $0 4 Feb 16, 2023 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Oct 3, 2022 5 -$1.61M 4 Oct 5, 2022 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Aug 10, 2022 3 -$1.43M 4 Aug 11, 2022 Chief Executive Officer, Director
RLAY Relay Therapeutics, Inc. Jul 25, 2022 1 $0 4 Jul 27, 2022 Director
RLAY Relay Therapeutics, Inc. Jul 25, 2022 0 $0 3 Jul 27, 2022 Director
VERV Verve Therapeutics, Inc. Jul 19, 2022 3 -$1.43M 4 Jul 21, 2022 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Jul 7, 2022 6 $0 4 Jul 15, 2022 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Mar 18, 2022 2 $200K 4 Mar 22, 2022 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Feb 11, 2022 1 $0 4 Feb 15, 2022 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Jan 4, 2022 3 -$72K 4 Jan 6, 2022 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Dec 27, 2021 8 -$1.89M 4 Dec 29, 2021 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Dec 22, 2021 9 -$4.32M 4 Dec 27, 2021 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Jun 17, 2021 2 $47.5K 4 Jun 21, 2021 Chief Executive Officer, Director
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Chief Executive Officer, Director, 10%+ Owner